Various inhibitors, including inhibitors of classical resistance‐related proteins, EGFR inhibitors, and sphingosine 1‐phosphate receptor (S1PR) modulators have been found to reverse chemoresistance in CRC. This evidence concerns the gene EGFR and colorectal carcinoma.